Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons

Journal of Alzheimer's Disease

Volumn 6, Issue 5, 2004, Pages 527-536

  Luo, LuGuang ^a,c   Stopa, Edward G ^b  

^a Department of Research   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Hippocampal neurons; PKA; PKC; Signal transduction; Src; Tau; TRH

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; ISOENZYME; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PHOSPHOTRANSFERASE; PROTEIN KINASE C INHIBITOR; PROTIRELIN; TAU PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN KINASE A KINASE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TAU PROTEINS; THYROTROPIN-RELEASING HORMONE;

EID: 16644394650     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6510     Document Type: Article

References (35)

1. J. Ahi, J. Radulovic and J. Spiess, The role of hippocampal signaling cascades in consolidation of fear memory, Behav Brain Res 149 (2004), 17-31.
2. M. Albert, M. Jenike, R. Nixon and K. Nobel, Thyrotropin response to thyrotropin-releasing hormone in patients with dementia of the Alzheimer type, Biol Psychiatry 33 (1993), 267-271.
3. S.E. Arnold, Part III. Neuropathology of Alzheimer's disease, Dis Mon 46 (2000), 687-705.
4. F.M. Benes, R.E. Burke, J. Walsh, S. Berretta, D. Matzilevich, M. Minns and C. Konradi, Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus, Mol Psychiatry Jun 1 (2004).
5. G.W. Bennett, T.M. Ballard, C.D. Watson and K.C. Fone, Effect of neuropeptides on cognitive function, Exp Gerontol 32 (1997), 451-469.
6. T. Blank, I. Nijholt, D.K. Grammatopoulos, H.S. Randeva, E.W. Hillhouse and J. Spiess, Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning, J Neurosci 23 (2003), 700-707.
7. H.X. Chen and S.N. Roper, PKA and PKC enhance excitatory synaptic transmission in human dentate gyrus, J Neurophysiol 89 (2003), 2482-2488.
8. D.A. Cross, A.A. Culbert, K.A. Chalmers, L. Facci, S.D. Skaper and A.D. Reith, Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death, J Neurochem 77 (2001), 94-102.
9. G.V. De Ferrari and N.C. Inestrosa, Wnt signaling function in Alzheimer's disease, Brain Res Brain Res Rev 33 (2000), 1-12.
10. W.P. Esler and M.S. Wolfe, A portrait of Alzheimer secretases-new features and familiar faces, Science 293 (2001), 1449-1454.
11. O.V. Forlenza, J.M. Spink, R. Dayanandan, B.H. Anderton, O.F. Olesen and S. Lovestone, Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons, J Neural Transm 107 (2000), 1201-1212.
12. K.A. Gary, K.A. Sevarino, G.G. Yarbrough, A.J. Prange, Jr. and A. Winokur, The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics, J Pharmacol Exp Ther 305 (2003), 410-416.
13. J.M. Gomez, M. Aguilar and J. Soler, Growth hormone and thyrotropin hormone secretion in Alzheimer's disease, J Nutr Health Aging 4 (2000), 229-232.
14. G.F. Hall and J. Yao, Neuronal morphology, axonal integrity, and axonal regeneration in situ are regulated by cytoskeletal phosphorylation in identified lamprey central neurons, Microsc Res Tech 48 (2000), 32-46.
15. I.M. Jackson and S. Reichlin, Thyrotropin-releasing hormone (TRH): distribution in hypothalamic and extrahypothalamic brain tissues of mammalian and submammalian chordates, Endocrinology 95 (1974), 854-862.
16. R.S. Jope, Cholinergic Muscarinic Receptor Signaling by the Phosphoinositide Signal Transduction System in Alzheimer's Disease, J Alzheimers Dis 1 (1999), 231-247.
17. R.M. Lechan, P. Wu, I.M. Jackson, H. Wolf, S. Cooperman, G. Mandel and R.H. Goodman, Thyrotropin-releasing hormone precursor: characterization in rat brain, Science 231 (1986), 159-161.
18. G. Lee, S.T. Newman, D.L. Gard, H. Band and G. Panchamoorthy, Tau interacts with src-family non-receptor tyrosine kinases, J Cell Sci 111(Pt 21) (1998), 3167-3177.
19. G. Lee, R. Thangavel, V.M. Sharma, J.M. Litersky, K. Bhaskar, S.M. Fang, L.H. Do, A. Andreadis, G. Van Hoesen and H. Ksiezak-Reding, Phosphorylation of tau by fyn: implications for Alzheimer's disease, J Neurosci 24 (2004), 2304-2312.
20. J.J. Lucas, F. Hernandez, P. Gomez-Ramos, M.A. Moran, R. Hen and J. Avila, Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice, Embo J 20 (2001), 27-39.
21. L. Luo, N. Yano, Q. Mao, I.M. Jackson and E.G. Stopa, Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients, J Alzheimers Dis 4 (2002), 97-103.
22. L.G. Luo, S. Wang, E. Su and I.M. Jackson, Evidence from studies with N-ethyl-maleimide and 12-O-tetradecanoylphorbol-13-acetate that AP-1 and CREB are involved in the glucocorticoid activation of TRH gene expression in hypothalamic cultures, Brain Res 841 (1999), 189-192.
23. C. Mailliot, T. Bussiere, M. Hamdane, N. Sergeant, M.L. Caillet, A. Delacourte and L. Buee, Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities, Ann N Y Acad Sci 920 (2000), 107-114.
24. F. Malchiodi-Albedi, T.C. Petrucci, B. Picconi, F. Iosi and M. Falchi, Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons, J Neurosci Res 48 (1997), 425-438.
25. E.M. Mandelkow and E. Mandelkow, Tau in Alzheimer's disease, Trends Cell Biol 8 (1998), 425-427.
26. H.K. Manji, G.J. Moore and G. Chen, Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness, J Clin Psychiatry 61 (2000), 82-96.
27. M. Ohmichi, T. Sawada, Y. Kanda, K. Koike, K. Hirota, A. Miyake and A.R. Saltiel, Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation, J Biol Chem 269 (1994), 3783-3788.
28. T. Palomero, F. Barros, D. del Camino, C.G. Viloria and P. de la Pena, A G protein beta gamma dimer-mediated pathway contributes to mitogen-activated protein kinase activation by thyrotropin-releasing hormone receptors in transfected COS-7 cells, Mol Pharmacol 53 (1998), 613-622.
29. A.C. Santucci and S. Perez, Multiple injections of thyrotropin releasing hormone fail to reverse learning and memory deficits in rats with lesions of the nucleus basalis of meynert, Behav Brain Res 136 (2002), 433-438.
30. T.B. Shea and M.L. Beermann, Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization, Mol Biol Cell 5 (1994), 863-875.
31. J. Smith, R. Yu and P.M. Hinkle, Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis, Mol Endocrinol 15 (2001), 1539-1548.
32. B. Steiner, E.M. Mandelkow, J. Biernat, N. Gustke, H.E. Meyer, B. Schmidt, G. Mieskes, H.D. Soling, D. Drechsel, M.W. Kirschner et al., Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles, Embo J 9 (1990), 3539-3544.
33. Y. Tanabe, H. Ishizu, K. Ishiguro, N. Itoh, S. Terada, T. Haraguchi, K. Kawai and S. Kuroda, Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation, Neuroreport 11 (2000), 2473-2477.
34. O.V. Vitolo, A. Sant'Angelo, V. Costanzo, F. Battaglia, O. Arancio and M. Shelanski, Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling, Proc Natl Acad Sci USA 99 (2002), 13217-13221.
35. M. Yamada and M. Mori, [Cloning and characterization of the human thyrotropin-releasing hormone receptor: regulation of thyrotropin-releasing hormone receptor mRNA levels by thyroid hormone], Nippon Rinsho 52 (1994), 1001-1006.